Efficacy of the Use of Silver Diamine Fluoride and Sodium Fluoride Varnish for the Treatment of Caries in Children
NCT ID: NCT05638217
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
199 participants
OBSERVATIONAL
2022-11-07
2023-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Efficacy of treatment of active tooth decay with the treatment protocol of 38% silver diamine fluoride and 5% sodium fluoride varnish.
* Clinical evaluation of tooth decay treated with 38% silver diamine fluoride and 5% sodium fluoride varnish in quality of hardness, color change and caries progression.
* Explore the association of treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish with: i. Reduction of oral pain caused by the presence of carious lesions. ii. Improvement in gingival oral health. iii. Changes in general nutritional status through measurements of height, weight, hemoglobin levels and nutritional survey. The participants will be identified, charted (with nutritional surveys and parameters), as well as treated and compared in a six- and twelve-month period, where researchers will clinically identify the association between the use of this protocol and the efficacy of such, as well as other related nutritional aspects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Silver Diamine Fluoride Gel: Case Series
NCT05395065
Treatment of Early Childhood Caries Using Silver Diammine Fluoride and Sodium Fluoride Tricalciumphosphate and the Effects on Oral Health Related Quality of Life
NCT05772039
Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride
NCT01563172
Treatment of Interproximal Cavities on Primary Molar Teeth With Silver Diamine Fluoride
NCT03770286
Effectiveness of Dental Caries Arrest Treatment in Primary Teeth Using AgNO3 Followed by NaF Varnish
NCT02019160
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients of 4 to 12 years old eligible to received dental cavity treatment
Patients of 4 to 12 years old that are eligible to received dental cavity treatment. The goal of this observational study is to identify the efficacy of silver diamine fluoride 38% followed by sodium fluoride varnish 5%, using "CaviGuard®" as delivery method, in a population with untreated dental caries age range 4 to 12 years old.
Silver diamine fluoride 38% followed by Sodium fluoride varnish 5%
1)Completely drying of the affected area 2)10 microliters of silver diamine fluoride 38% (CaviGuard®) will be placed on the affected area 3)The affected area should be immediately covered with 20 microliters of fluoride varnish 5% (CaviGuard®) 4)Repeat steps 1-3 one or two more times for large caries at intervals of at least 2 days apart 5)Follow up evaluation of treatment success visits will be conducted at 6 and 12 months from the initial treatment.
NOTE: This is a single intervention using the device registered as Caviguard® to apply both products (Silver diamine fluoride 38% followed by Sodium fluoride varnish 5% (®)) in sequence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Silver diamine fluoride 38% followed by Sodium fluoride varnish 5%
1)Completely drying of the affected area 2)10 microliters of silver diamine fluoride 38% (CaviGuard®) will be placed on the affected area 3)The affected area should be immediately covered with 20 microliters of fluoride varnish 5% (CaviGuard®) 4)Repeat steps 1-3 one or two more times for large caries at intervals of at least 2 days apart 5)Follow up evaluation of treatment success visits will be conducted at 6 and 12 months from the initial treatment.
NOTE: This is a single intervention using the device registered as Caviguard® to apply both products (Silver diamine fluoride 38% followed by Sodium fluoride varnish 5% (®)) in sequence.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children within the age range mentioned above.
* Require a completed informed consent form and completed nutritional survey record for anyone who will participate in the program.
* According to the evaluation of the dentist Caries grade I and grade II
* In the case of patients with disabilities, at least one parent or legal guardian must be present at all times during the study.
Exclusion Criteria
* Patients with caries with grade III or grade IV
* Patients with a known allergy to any of the active ingredients ( 38% silver diamine fluoride and 5% sodium fluoride varnish)
* Patients who were unable to give their informed consent or complete the nutritional survey.
* Patients who cannot participate during the entire program (12 months).
* Patients with other oral treatments (Orthodontics).
* Patients who are not present with at least one parent or legal guardian at the time of treatment.
4 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Privada del Valle, Sede Cochabamba
UNKNOWN
Industria Química Farmacéutica SIGMA CORP S.R.L. Cochabamba, Bolivia
UNKNOWN
NODK LLC, Oregón, EE. UU.
UNKNOWN
Food Bank Bolivia
UNKNOWN
Universidad Mayor de San Simón
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rodrigo Arce Cardozo
Associate Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathaly Campero Ferrufino, DDS
Role: PRINCIPAL_INVESTIGATOR
Private University of the Valley
Ximena Claros Martinez, DDS
Role: PRINCIPAL_INVESTIGATOR
Private University of the Valley
Edwin Guarayo Molina, DDS
Role: PRINCIPAL_INVESTIGATOR
Private University of the Valley
Rodrigo k Arce Cardozo, MD, MPH,
Role: PRINCIPAL_INVESTIGATOR
Universidad Mayor de San Simon
Steve Duffin, DDS
Role: PRINCIPAL_INVESTIGATOR
NODK LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolivian Food Bank Foundation
Cochabamba, , Bolivia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Description Intervention
Private University of the Valley
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DINV-CAV01-EC001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.